THRA and breast carcinoma: Historically, THRA (Thyroid Hormone Receptor Alpha) has been used to delineate the locus linked to breast cancer including BRCA1. A detailed deletion mapping of chromosome segment 17q12–21 in sporadic breast tumours showed that the pattern of LOH covered the BRCA1 and THRA locus [53].